Cargando…

CTS Trials Network: A paradigm shift in the surgical treatment of moderate ischemic mitral regurgitation?

The Cardiothoracic Surgery Trials Network has reported results of the one-year follow up of their randomized trial “Surgical Treatment of Moderate Ischemic Mitral Regurgitation”. They studied 301 patients with moderate ischemic mitral regurgitation (IMR) undergoing coronary artery bypass grafting (C...

Descripción completa

Detalles Bibliográficos
Autor principal: Afifi, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bloomsbury Qatar Foundation Journals 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633578/
https://www.ncbi.nlm.nih.gov/pubmed/26779511
http://dx.doi.org/10.5339/gcsp.2015.30
_version_ 1782399227327938560
author Afifi, Ahmed
author_facet Afifi, Ahmed
author_sort Afifi, Ahmed
collection PubMed
description The Cardiothoracic Surgery Trials Network has reported results of the one-year follow up of their randomized trial “Surgical Treatment of Moderate Ischemic Mitral Regurgitation”. They studied 301 patients with moderate ischemic mitral regurgitation (IMR) undergoing coronary artery bypass grafting (CABG) with or without mitral repair with the primary end-point of change in left ventricular end-diastolic volume index (LVEDVI) at one year and multiple clinical and echocardiographic secondary endpoints. Although their results were against repairing the mitral valve, the debate on surgical management of moderate IMR remains unsettled.
format Online
Article
Text
id pubmed-4633578
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Bloomsbury Qatar Foundation Journals
record_format MEDLINE/PubMed
spelling pubmed-46335782016-01-15 CTS Trials Network: A paradigm shift in the surgical treatment of moderate ischemic mitral regurgitation? Afifi, Ahmed Glob Cardiol Sci Pract Lessons from the Trials The Cardiothoracic Surgery Trials Network has reported results of the one-year follow up of their randomized trial “Surgical Treatment of Moderate Ischemic Mitral Regurgitation”. They studied 301 patients with moderate ischemic mitral regurgitation (IMR) undergoing coronary artery bypass grafting (CABG) with or without mitral repair with the primary end-point of change in left ventricular end-diastolic volume index (LVEDVI) at one year and multiple clinical and echocardiographic secondary endpoints. Although their results were against repairing the mitral valve, the debate on surgical management of moderate IMR remains unsettled. Bloomsbury Qatar Foundation Journals 2015-10-06 /pmc/articles/PMC4633578/ /pubmed/26779511 http://dx.doi.org/10.5339/gcsp.2015.30 Text en © 2015 Afifi, licensee Bloomsbury Qatar Foundation Journals. This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Lessons from the Trials
Afifi, Ahmed
CTS Trials Network: A paradigm shift in the surgical treatment of moderate ischemic mitral regurgitation?
title CTS Trials Network: A paradigm shift in the surgical treatment of moderate ischemic mitral regurgitation?
title_full CTS Trials Network: A paradigm shift in the surgical treatment of moderate ischemic mitral regurgitation?
title_fullStr CTS Trials Network: A paradigm shift in the surgical treatment of moderate ischemic mitral regurgitation?
title_full_unstemmed CTS Trials Network: A paradigm shift in the surgical treatment of moderate ischemic mitral regurgitation?
title_short CTS Trials Network: A paradigm shift in the surgical treatment of moderate ischemic mitral regurgitation?
title_sort cts trials network: a paradigm shift in the surgical treatment of moderate ischemic mitral regurgitation?
topic Lessons from the Trials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633578/
https://www.ncbi.nlm.nih.gov/pubmed/26779511
http://dx.doi.org/10.5339/gcsp.2015.30
work_keys_str_mv AT afifiahmed ctstrialsnetworkaparadigmshiftinthesurgicaltreatmentofmoderateischemicmitralregurgitation